The Role of Glutathione in Age-Related Macular Degeneration (AMD).
Level 5 - mechanism / opinion, no new human data
Narrative review synthesizing mechanistic and observational studies without systematic methodology
PubMed 38673745 · doi:10.3390/ijms25084158
What was done
This narrative review summarizes published literature examining the role of reduced glutathione (GSH), glutathione-related enzymes (glutathione S-transferase [GST], glutathione reductase [GR], and glutathione peroxidase [GPx]), and polymorphisms in GSTT1 and GSTM1 in the pathogenesis of age-related macular degeneration (AMD). The authors explicitly restricted their selection to papers confirming an influence on AMD development.
What was found
No numerical data, effect sizes, or study counts are reported in the abstract. The authors note that GST activity is consistently elevated in patients with AMD, whereas findings for GPx activity are contradictory (showing both increased and decreased activity depending on the study). Similarly, evidence for an association between GST gene polymorphisms and AMD is conflicting, with some studies finding an association with weakened antioxidant barriers while meta-analyses and other studies show no link.
Why it matters
The review maps current mechanistic hypotheses regarding glutathione-dependent antioxidant defense in retinal aging, highlighting substantial inconsistencies in the genetic and biochemical literature.
Limits
The review is narrative rather than systematic, and the authors explicitly introduced selection bias by deliberately selecting only papers reporting positive associations. Findings across the broader literature remain conflicting regarding GPx activity and GST polymorphism risks. No quantitative synthesis or sample sizes are provided in the abstract.
Cited by
- supports Glutathione is an endogenous tripeptide made up of three amino acids and is present at high levels in the retina and macula of the eye.